Who Paid My Doc
Todd Lefkowitz
Plastic and Reconstructive Surgery West Columbia, SC Medical Doctor
NPI 1134362320 CMS profile 51014
2728 Sunset Blvd, Ste 105, West Columbia, SC 29169
General payments
$3,295
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Todd Lefkowitz of West Columbia, SC is reported in the CMS Open Payments database as having received $3,295 across 63 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 60th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,110 | 7 | |
| 2024 | General | $85 | 4 | |
| 2023 | General | $240 | 11 | |
| 2022 | General | $369 | 9 | |
| 2021 | General | $322 | 11 | |
| 2020 | General | $507 | 9 | |
| 2019 | General | $661 | 12 |
Beside peers
- Todd Lefkowitz
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Todd Lefkowitz were reported at $1,110. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Todd Lefkowitz | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $661 | $335 | $121–$1,264 | $163 |
| 2020 | $507 | $162 | $57–$417 | $114 |
| 2021 | $322 | $245 | $89–$735 | $132 |
| 2022 | $369 | $325 | $120–$932 | $149 |
| 2023 | $240 | $343 | $129–$999 | $160 |
| 2024 | $85 | $390 | $141–$1,085 | $164 |
| 2025 | $1,110 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
63
Drug cost
$394
Branded share of claims
42.9%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Doxycycline Monohydrate | Generic | 19 | $164 | |
| Mupirocin | Generic | 17 | $142 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 14 | $51 | |
| Ondansetron Odt Ondansetron | Brand | 13 | $37 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.
Records
63 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in South Carolina
Arthur Nam
Plastic and Reconstructive Surgery · West Columbia, SC
Sami Tarabishy
Plastic and Reconstructive Surgery · Mount Pleasant, SC
Patrick O Neill
Plastic and Reconstructive Surgery · Daniel Island, SC
Fernando Herrera
Plastic and Reconstructive Surgery · Charleston, SC
Dustin Eck
Plastic and Reconstructive Surgery · Myrtle Beach, SC
Federico Perez Quirante
Plastic and Reconstructive Surgery · Mt Pleasant, SC
Related records
Plastic and Reconstructive Surgery in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.